China challenges US in new drugs after industry transformation



China challenges US in new drugs after industry transformation
In barely a decade, China has transformed from a maker of cheap generic copies of Western medicines into a global powerhouse of pharmaceutical innovation.
The country now only trails the United States in novel drugs under development, with a 29 per cent share, according to McKinsey. International pharmaceutical companies are beating a path to China’s shores to license next-generation treatments for cancer, autoimmune diseases and other disorders.
Government support, including regulatory and…

  • Related Posts

    ‘Who the hell was driving the Tesla’: Meta AI chief on Musk’s flying car post

    Meta AI chief Alexandr Wang reacted with a cheeky question to Elon Musk’s post about a flying Tesla, triggering fresh online chatter around the tech billionaire’s futuristic vision for transportation.…

    Continue reading
    ‘We can’t be splurging money’: Sitharaman on India’s growth, China trade gap

    Sitharaman says infrastructure spending, fiscal discipline and new trade deals will drive India’s growth, while flagging trade gaps with China and Asean India’s growth outlook remains strong, but its dependence…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *